Ethylestrenol
Systematic (IUPAC) name | |
---|---|
(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl- 2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro- 1H-cyclopenta[a]phenanthren-17-ol | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Identifiers | |
CAS Number | 965-90-2 |
ATC code | A14AB02 (WHO) |
PubChem | CID 13765 |
IUPHAR/BPS | 6948 |
DrugBank | DB01493 |
ChemSpider | 13168 |
UNII | ADC79EK5Q8 |
KEGG | D01414 |
ChEBI | CHEBI:31578 |
ChEMBL | CHEMBL1200623 |
Chemical data | |
Formula | C20H32O |
Molar mass | 288.467 g/mol |
| |
| |
(what is this?) (verify) |
Ethylestrenol (brand names Maxibolin, Orabolin), also known as 17α-ethylestr-4-en-17β-ol, is an anabolic steroid with some progestogenic activity, and little androgenic activity. It is a nandrolone derivative and lacks the 3-keto functional group. It was approved in 1964 for testosterone deficiency in male patients.[1]
See also
- Nandrolone (17β-hydroxyestra-4-en-3-one)
- Ethisterone (17α-ethynyl-17β-hydroxyandrost-4-en-3-one)
References
|
|
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.